The team
Disperazol’s team is expereinced, with an established track record of long term collaboration and success.
-

Prof Michael Givskov
Head of Science
Inventor of Disperazol.
40 years experience in research and technology start-ups, as research leader and entrepreneur.
Founded the Costerton Biofilm Center (Denmark) and co-founded the SCELSE Research Centre (Singapore).
-

Dr Michael Graz
CEO
30 years of experience in medical technology and biotechnology start ups and SMEs.
Has previously obtained Orphan Designation for a non traditional antimicrobial for which he raised USD15 Mn in follow-on funding for antibiotic development.
-

Prof MD Claus Moser
CMO
Chief Physician at Rigshospitalet in Copenhagen, Denmark.
Specialised in clinical microbiology.
Borregaard Clinical Scientist Fellowship from Novo Nordic Foundation in 2017.
-

Dr Stewart Clark
Regulatory Advisor
CSO at Fulhold Pharma, Head of Compliance at Biophys Ltd.
Specialised in GXP.
Previous Fulbright Scholar at the Center for Biofilm Engineering at Montana State University in the USA.
-
Assoc Prof Louise D. Hultqvist
Inventor of Disperazol.
Assoc Prof Jens Bo Andersen
Inventor of Disperazol.
-
Chief Surgeon MD, PhD Klaus Kirketerp-Møller
Copenhagen Wound Healing Center, Department of Dermatology and Wounds, Bispebjerg University Hospital and Steno Diabetes Center Copenhagen.